Results of recent key studies such as Losartan Intervention For Endpoint Reduction in Hypertension (LIFE), Valsartan in Heart Failure Trial (Val-HeFT), Candesartan in Heart Failure Assessment of ...
Hosted on MSN2mon
FDA recalls more than 233,000 bottles of antidepressant over possible cancerous chemicalMore than 12 million bottles of blood pressure-lowering drugs such as valsartan and losartan have been removed from the market since 2018 because they contained nitrosamines.
[51] The primary endpoint favoured losartan (RR 0.87 ... to placebo to the extent previously thought. [52] The VALUE (Valsartan Antihypertensive Long-Term Use Evaluation) trial was a randomised ...
More than 12 million bottles of blood pressure-lowering drugs such as valsartan and losartan have been removed from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback